XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional paid-in capital
Statutory reserve
Accumulated Deficits
Accumulative Other comprehensive income
Non-controlling interests
Total
Balance at Dec. 31, 2022 $ 14,646 $ 222,751,657 $ 98,357 $ (152,276,434) $ (3,623,005) $ (1,279,580) $ 65,685,641
Balance (in Shares) at Dec. 31, 2022 14,645,653            
Net loss from continued operation       (2,068,136)   (71,013) (2,139,149)
Net loss from discontinued operations       (108,328)     (108,328)
Unrealized holding gains/(losses) on available-for-sale securities         180,851   180,851
Disposition of Discontinued operation         26,317   26,317
Foreign currency translation adjustment         377,772   (377,772)
Balance at Mar. 31, 2023 $ 14,646 222,751,657 98,357 (154,452,898) (3,038,065) (1,350,593) 64,023,104
Balance (in Shares) at Mar. 31, 2023 14,645,653            
Balance at Dec. 31, 2023 $ 17,835 233,890,997 98,357 (185,929,662) (4,094,276) (1,568,207) $ 42,415,044
Balance (in Shares) at Dec. 31, 2023 17,834,874           17,834,874
Net loss from continued operation       (3,972,645)   3,579 $ (3,969,066)
Issuance of common stocks-non cash $ 2,150 2,578,493   2,580,643
Issuance of common stocks-non cash (in Shares) 2,150,536            
Net loss from discontinued operations            
Unrealized holding gains/(losses) on available-for-sale securities            
Disposition of Discontinued operation       645,437     645,437
Foreign currency translation adjustment         (47,624)   (47,624)
Balance at Mar. 31, 2024 $ 19,985 $ 236,469,490 $ 98,357 $ (189,256,870) $ (4,141,900) $ (1,564,628) $ 41,624,434
Balance (in Shares) at Mar. 31, 2024 19,985,410           19,985,410